Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangdon Han

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|December 24, 2014
Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptorDaniel J Buzard, Thomas O Schrader, Xiuwen Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluationGraeme Semple, Thuy-Anh Tran, Bryan Kramer, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Discovery of APD371: Identification of a Highly Potent and Selective CB<sub>2</sub> Agonist for the Treatment of Chronic PainSangdon Han, Lars Thoresen, Jae-Kyu Jung, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2022
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinismJian Zhao, Shimiao Wang, Sun Hee Kim, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonistsDaniel Buzard, Sangdon Han, Lars Thoresen, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2014
Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonistsDaniel J Buzard, Sun Hee Kim, Juerg Lehmann, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist seriesSangdon Han, Sanju Narayanan, Sun Hee Kim, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2012
Fused tricyclic indoles as S1P₁ agonists with robust efficacy in animal models of autoimmune diseaseDaniel J Buzard, Sangdon Han, Luis Lopez, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2014
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonistsSangdon Han, Lars Thoresen, Xiuwen Zhu, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 ReceptorDaniel J Buzard, Sun Hee Kim, Luis Lopez, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|December 24, 2014
Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptorDaniel J Buzard, Thomas O Schrader, Xiuwen Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluationGraeme Semple, Thuy-Anh Tran, Bryan Kramer, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Discovery of APD371: Identification of a Highly Potent and Selective CB<sub>2</sub> Agonist for the Treatment of Chronic PainSangdon Han, Lars Thoresen, Jae-Kyu Jung, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2022
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinismJian Zhao, Shimiao Wang, Sun Hee Kim, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonistsDaniel Buzard, Sangdon Han, Lars Thoresen, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2014
Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonistsDaniel J Buzard, Sun Hee Kim, Juerg Lehmann, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist seriesSangdon Han, Sanju Narayanan, Sun Hee Kim, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2012
Fused tricyclic indoles as S1P₁ agonists with robust efficacy in animal models of autoimmune diseaseDaniel J Buzard, Sangdon Han, Luis Lopez, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2014
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonistsSangdon Han, Lars Thoresen, Xiuwen Zhu, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 ReceptorDaniel J Buzard, Sun Hee Kim, Luis Lopez, et al.
Pageof 2